• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ferrer - Articles and news items

Ergomed and Ferrer complete recruitment for Phase IIa insomnia clinical trial

Industry news / 13 September 2016 / Niamh Louise Marriott, Digital Content Producer

The effects of lorediplon (5 and 10 mg) are being compared to both placebo and zolpidem. The aim of the study is to evaluate the appropriate effective dose of lorediplon, to further characterise its efficacy on sleep maintenance/sleep quality and to evaluate any next day hangover effects in adult patients with insomnia disorder…

Ferrer initiates Phase IIa clinical study of Lorediplon in patients with insomnia

Industry news / 14 July 2015 / Victoria White

The first patient has been recruited into a Phase IIa clinical trial to test the efficacy, safety and tolerability profile of Lorediplon in insomnia…